ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification. - Huang, Zhe; Hu, Xu; Wei, Yiqiu; Lai, Yousheng; Qi, Jiaming; Pang, Jinglin; Huang, Kang; Li, Huagui; Cai, Pengzhu (PLoS ONE, 2024)